Acute Research Profile
Key Indicators
- Authorised Capital ₹ 5.00 K
as on 24-10-2024
- Paid Up Capital ₹ 5.00 K
as on 24-10-2024
- Company Age 7 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.90 Cr
as on 24-10-2024
- Revenue -32.14%
(FY 2023)
- Profit -133.00%
(FY 2023)
- Ebitda -363.35%
(FY 2023)
- Net Worth -16.04%
(FY 2023)
- Total Assets -19.91%
(FY 2023)
About Acute Research
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 K and a paid-up capital of Rs 5.00 K .
The company currently has active open charges totaling ₹11.90 Cr.
Daxaben Patel and Vishal Patel serve as directors at the Company.
- CIN/LLPIN
U73100GJ2017PTC099342
- Company No.
099342
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2017
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acute Research Private Limited offer?
Acute Research Private Limited offers a wide range of products and services, including Cleaning Liquids & Wipes, Kitchen Cleaners, Pharma Ingredients & Raw Materials, Antipyretic and Analgesic API, Animal Medicines & Health Care, Veterinary Medicines, API (Active Pharmaceutical Ingredients), Cardiovascular Drugs & Medication, Anticoagulant and Antiplatelet Drugs, Anti Infective API.
Who are the key members and board of directors at Acute Research?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Daxaben Patel  | Director | 04-Oct-2017 | Current |
| Vishal Patel | Director | 04-Oct-2017 | Current |
Financial Performance of Acute Research.
Acute Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.14% decrease. The company also saw a substantial fall in profitability, with a 133% decrease in profit. The company's net worth observed a substantial decline by a decrease of 16.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acute Research?
In 2023, Acute Research had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sunflower Women's Endo Infertility And Hospital Private LimitedActive 16 years 1 monthVishal Patel is a mutual person
Noacheean Engineers And Consultants Private LimitedActive 6 years 10 monthsVishal Patel is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 30 Sep 2019 | ₹5.95 Cr | Open |
Hdfc Bank Limited Creation Date: 18 Sep 2019 | ₹5.95 Cr | Open |
How Many Employees Work at Acute Research?
Acute Research has a workforce of 9 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acute Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acute Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
_PRIVATE_LIMITED_354462.webp){kind=small}
